These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29722569)

  • 21. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.
    Abuid J; Larsen PR
    J Clin Invest; 1974 Jul; 54(1):201-8. PubMed ID: 4134836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
    Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
    Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
    J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical effect of methimazole on liver mitochondria: In vitro and in vivo.
    Niknahad H; Jamshidzadeh A; Heidari R; Hosseini Z; Mobini K; Khodaei F; Ommati MM; Abdoli N; Keshavarz N; Bazyari M; Najibi A
    Toxicol Lett; 2016 Sep; 259():108-115. PubMed ID: 27506418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonyl traps as potential protective agents against methimazole-induced liver injury.
    Heidari R; Niknahad H; Jamshidzadeh A; Azarpira N; Bazyari M; Najibi A
    J Biochem Mol Toxicol; 2015 Apr; 29(4):173-81. PubMed ID: 25545158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
    J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
    Akmal A; Kung J
    Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of selenium on methimazole-induced liver damage and oxidative stress in adult rats and their offspring.
    Sefi M; Ben Amara I; Troudi A; Soudani N; Hakim A; Zeghal KM; Boudawara T; Zeghal N
    Toxicol Ind Health; 2014 Aug; 30(7):653-69. PubMed ID: 23047615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Asymptomatic hepatitis induced by propylthiouracil].
    De Castro JJ; Nobre EL; Garcia e Costa J; Galvão-Teles A
    Acta Med Port; 2001; 14(5-6):523-7. PubMed ID: 11878166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The propylthiouracil dilemma.
    Glinoer D; Cooper DS
    Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):402-7. PubMed ID: 22820213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury.
    Tukov FF; Luyendyk JP; Ganey PE; Roth RA
    Toxicol Sci; 2007 Nov; 100(1):267-80. PubMed ID: 17698507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of hepatic fibrin in idiosyncrasy-like liver injury from lipopolysaccharide-ranitidine coexposure in rats.
    Luyendyk JP; Maddox JF; Green CD; Ganey PE; Roth RA
    Hepatology; 2004 Dec; 40(6):1342-51. PubMed ID: 15565632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
    Yang J; Li LF; Xu Q; Zhang J; Weng WW; Zhu YJ; Dong MJ
    Thyroid; 2015 Mar; 25(3):278-83. PubMed ID: 25384184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats.
    Motonaga K; Ota M; Odawara K; Saito S; Welsch F
    Regul Toxicol Pharmacol; 2016 Oct; 80():283-90. PubMed ID: 27350053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease.
    Kallner G; Vitols S; Ljunggren JG
    J Intern Med; 1996 Jun; 239(6):525-9. PubMed ID: 8656146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of Salvia miltiorrhiza and Carthamus tinctorius extract against lipopolysaccharide-induced liver injury.
    Gao LN; Yan K; Cui YL; Fan GW; Wang YF
    World J Gastroenterol; 2015 Aug; 21(30):9079-92. PubMed ID: 26290634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children.
    Rivkees SA; Szarfman A
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3260-7. PubMed ID: 20427502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipopolysaccharide augments aflatoxin B(1)-induced liver injury through neutrophil-dependent and -independent mechanisms.
    Barton CC; Ganey PE; Roth RA
    Toxicol Sci; 2000 Nov; 58(1):208-15. PubMed ID: 11053557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The selenium analog of methimazole. Measurement of its inhibitory effect on type I 5'-deiodinase and of its antithyroid activity.
    Taurog A; Dorris ML; Guziec LJ; Guziec FS
    Biochem Pharmacol; 1994 Oct; 48(7):1447-53. PubMed ID: 7524506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.